TY - JOUR T1 - Personalising care: using infliximab drug trough and anti-drug antibody levels improves clinical treatment decisions and is a cost-effective strategy in spondyloarthritis JF - Clinical Medicine JO - Clin Med SP - 106 LP - 107 DO - 10.7861/clinmedicine.19-2-s106 VL - 19 IS - Suppl 2 AU - Sayam Dubash AU - Domini Bryer AU - John Fitton AU - Andrew Barr AU - Claire Vandevelde AU - Helena Marzo-Ortega AU - Jane Freeston Y1 - 2019/03/01 UR - http://www.rcpjournals.org/content/19/Suppl_2/106.abstract ER -